Bernstein Bank Forecasts Strong Price Appreciation for Intuitive Surgical (NASDAQ:ISRG) Stock

Intuitive Surgical (NASDAQ:ISRG - Free Report) had its price objective upped by Bernstein Bank from $655.00 to $700.00 in a research report sent to investors on Monday, MarketBeat Ratings reports. The brokerage currently has an overweight rating on the medical equipment provider's stock.

Several other equities research analysts have also recently commented on the stock. The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a research report on Friday, October 18th. Mizuho upped their target price on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. BTIG Research raised their price target on Intuitive Surgical from $535.00 to $561.00 and gave the company a "buy" rating in a research note on Tuesday, November 26th. Robert W. Baird upped their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the stock an "outperform" rating in a research note on Thursday, October 17th. Finally, Leerink Partners raised their target price on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $613.10.

Intuitive Surgical Stock Up 0.1 %

Shares of NASDAQ:ISRG traded up $0.70 during midday trading on Monday, reaching $574.18. 1,780,779 shares of the company were exchanged, compared to its average volume of 2,005,748. The firm has a market cap of $204.51 billion, a PE ratio of 92.31, a P/E/G ratio of 5.19 and a beta of 1.39. Intuitive Surgical has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The stock has a fifty day simple moving average of $548.00 and a two-hundred day simple moving average of $506.12.

Insider Activity at Intuitive Surgical

In other news, CEO Gary S. Guthart sold 18,151 shares of the business's stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the transaction, the chief executive officer now directly owns 24,219 shares in the company, valued at approximately $12,391,166.97. The trade was a 42.84 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Jamie Samath sold 22,903 shares of the stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the sale, the insider now owns 8,757 shares in the company, valued at $4,597,425. This represents a 72.34 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 42,265 shares of company stock worth $21,964,281. Company insiders own 0.90% of the company's stock.

Hedge Funds Weigh In On Intuitive Surgical

A number of institutional investors and hedge funds have recently bought and sold shares of the company. Mirador Capital Partners LP lifted its holdings in Intuitive Surgical by 1.4% in the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider's stock valued at $1,732,000 after buying an additional 50 shares during the period. M.E. Allison & CO. Inc. purchased a new position in shares of Intuitive Surgical in the 4th quarter worth about $449,000. Seilern Investment Management Ltd bought a new position in Intuitive Surgical during the fourth quarter valued at $82,517,000. Exome Asset Management LLC increased its stake in shares of Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider's stock worth $3,649,000 after purchasing an additional 1,069 shares in the last quarter. Finally, Consolidated Planning Corp grew its position in shares of Intuitive Surgical by 17.4% in the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider's stock valued at $3,979,000 after purchasing an additional 1,198 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.